The stock market is getting Ozempic'ed

Tech Insider
A poultice with the anti-diabetic medication Ozempic is pictured in a pharmacy
Ozempic is a diabetic medication.

Florian Gaertner/Photothek via Getty Images

Eli Lilly's Obesity Drug Helped People Lose 25% of Their Weight in Latest Trial

Gizmodo

New research suggests that Eli Lilly’s tirzepatide can boost existing efforts to lose weight. The company’s latest clinical trial found that people who dropped at least 5% of their weight before taking the drug went on to lose substantially more weight than those who took a placebo. Those in the treatment group…

Read more...

The disruptive effect of weight loss drugs like Ozempic could have surprising impacts on the stock market. Here are potential winners and losers.

Tech Insider
weight loss scale

JGI/Jamie Grill/Getty Images

Eli Lilly Is on the Warpath, Now Suing Pharmacies and Spas for Selling Compounded Mounjaro

Gizmodo

The arms race over the next generation of obesity drugs is continuing to heat up.

2 huge employers just said they're dumping Wegovy from their health plans. It's a sign of a crackdown on popular weight-loss drugs.

Tech Insider
Health Weightloss Scale

Crystal Cox/Business Insider

Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that.

Tech Insider
Three boxes of Wegovy on a light wood counter

picture alliance/Getty Images

Americans desperate for the hot weight-loss drug Ozempic are turning to Canada and Mexico because they can't afford it at home

Tech Insider
A hand reaching across a US flag to an image of a Canadian flag to grab a box of Ozempic and pull it back over the US flag.

iStock; Rebecca Zisser/Insider

Subscribe to mounjaro